Establishment of a prognostic model for pancreatic cancer based on vesicle-mediated transport protein-related genes

References

• Adams SD, Csere J, D'angelo G, Carter EP, Romao M, Arnandis T, Dodel M, Kocher HM, Grose R, Raposo G, et al. 2021. Centrosome amplification mediates small extracellular vesicle secretion via lysosome disruption. Curr Biol. 31(7):1403–1416 e7. doi: 10.1016/j.cub.2021.01.028.
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Luo K, Zhang W, Reza Aref A, Zhang X. 2024. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: environmental factors, molecular profile and drug/nanotherapeutic approaches. Environ Res. 240(Pt 2):117443. doi: 10.1016/j.envres.2023.117443.
   PubMedGoogle Scholar
• Blanche P, Dartigues JF, Jacqmin-Gadda H. 2013. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 32(30):5381–5397. doi: 10.1002/sim.5958.
   PubMed Web of Science ®Google Scholar
• Böker V, Häußler J, Baumann J, Sunami Y, Trojanowicz B, Harwardt B, Hammje K, von Auw N, Erkan M, Krohn K, et al. 2022. Analysis of genomic alterations in cancer associated human pancreatic stellate cells. Sci Rep. 12(1):13532. doi: 10.1038/s41598-022-17748-1.
   PubMed Web of Science ®Google Scholar
• Bonifacino JS. 2004. The GGA proteins: adaptors on the move. Nat Rev Mol Cell Biol. 5(1):23–32. doi: 10.1038/nrm1279.
   PubMed Web of Science ®Google Scholar
• Brena D, Huang MB, Bond V. 2022. Extracellular vesicle-mediated transport: reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis. Transl Oncol. 15(1):101286. doi: 10.1016/j.tranon.2021.101286.
   PubMed Web of Science ®Google Scholar
• Cai J, Chen H, Lu M, Zhang Y, Lu B, You L, Zhang T, Dai M, Zhao Y. 2021. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett. 520:1–11. doi: 10.1016/j.canlet.2021.06.027.
   PubMed Web of Science ®Google Scholar
• Chang Y-T, Peng H-Y, Hu C-M, Tien S-C, Chen Y-I, Jeng Y-M, Chang M-C. 2023. Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways. Mol Oncol. 17(8):1628–1647. doi: 10.1002/1878-0261.13442.
   PubMed Web of Science ®Google Scholar
• D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS, O'Neill JR, Hoelscher A, Piessen G, van Lanschot J, et al. 2021. Risk prediction model of 90-day mortality after esophagectomy for cancer. JAMA Surg. 156(9):836–845. doi: 10.1001/jamasurg.2021.2376.
   PubMed Web of Science ®Google Scholar
• Hessmann E, Buchholz SM, Demir IE, Singh SK, Gress TM, Ellenrieder V, Neesse A. 2020. Microenvironmental determinants of pancreatic cancer. Physiol Rev. 100(4):1707–1751. doi: 10.1152/physrev.00042.2019.
   PubMed Web of Science ®Google Scholar
• Huang J, Lok V, Ngai CH, Zhang L, Yuan J, Lao XQ, Ng K, Chong C, Zheng Z-J, Wong MCS, et al. 2021. Worldwide burden of, risk factors for, and trends in pancreatic cancer. Gastroenterology. 160(3):744–754. doi: 10.1053/j.gastro.2020.10.007.
   PubMed Web of Science ®Google Scholar
• Klein AP. 2021. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 18(7):493–502. doi: 10.1038/s41575-021-00457-x.
   PubMed Web of Science ®Google Scholar
• Kunzmann V, Siveke JT, Algül H, Goekkurt E, Siegler G, Martens U, Waldschmidt D, Pelzer U, Fuchs M, Kullmann F, et al. 2021. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 6(2):128–138. doi: 10.1016/S2468-1253(20)30330-7.
   PubMed Web of Science ®Google Scholar
• Lan B, Zeng S, Grützmann R, Pilarsky C. 2019. The role of exosomes in pancreatic cancer. Int J Mol Sci. 20(18):4332. doi: 10.3390/ijms20184332.
   Web of Science ®Google Scholar
• Liu W-J, Zhou L, Liang Z-Y, Zhou W-X, You L, Zhang T-P, Zhao Y-P. 2018. High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma. Pathol Res Pract. 214(2):228–232. doi: 10.1016/j.prp.2017.11.013.
   PubMed Web of Science ®Google Scholar
• Maacha S, Bhat AA, Jimenez L, Raza A, Haris M, Uddin S, Grivel J-C. 2019. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance. Mol Cancer. 18(1):55. doi: 10.1186/s12943-019-0965-7.
   PubMedGoogle Scholar
• Maeser D, Gruener RF, Huang RS. 2021. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 22:bbab260.
   PubMed Web of Science ®Google Scholar
• Nabb AT, Frank M, Bentley M. 2020. Smart motors and cargo steering drive kinesin-mediated selective transport. Mol Cell Neurosci. 103:103464. doi: 10.1016/j.mcn.2019.103464.
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH. 2018. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 15(6):333–348. doi: 10.1038/s41575-018-0005-x.
   PubMed Web of Science ®Google Scholar
• Nishimoto A. 2022. Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment. World J Gastroenterol. 28(28):3637–3643. doi: 10.3748/wjg.v28.i28.3637.
   PubMed Web of Science ®Google Scholar
• O'Farrell H, Harbourne B, Kurlawala Z, Inoue Y, Nagelberg AL, Martinez VD, Lu D, Oh MH, Coe BP, Thu KL, et al. 2019. Integrative genomic analyses identifies GGA2 as a cooperative driver of EGFR-mediated lung tumorigenesis. J Thorac Oncol. 14(4):656–671. doi: 10.1016/j.jtho.2018.12.004.
   PubMed Web of Science ®Google Scholar
• Oliveira G, Wu CJ. 2023. Dynamics and specificities of T cells in cancer immunotherapy. Nat Rev Cancer. 23(5):295–316. doi: 10.1038/s41568-023-00560-y.
   PubMed Web of Science ®Google Scholar
• Patten DA, Wilkinson AL, O'Rourke JM, Shetty S. 2020. Prognostic value and potential immunoregulatory role of SCARF1 in hepatocellular carcinoma. Front Oncol. 10:565950. doi: 10.3389/fonc.2020.565950.
   PubMed Web of Science ®Google Scholar
• Patten DA. 2018. SCARF1: a multifaceted, yet largely understudied, scavenger receptor. Inflamm Res. 67(8):627–632. doi: 10.1007/s00011-018-1154-7.
   PubMed Web of Science ®Google Scholar
• Pitcher JA, Freedman NJ, Lefkowitz RJ. 1998. G protein-coupled receptor kinases. Annu Rev Biochem. 67:653–692. doi: 10.1146/annurev.biochem.67.1.653.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26(1):139–140. doi: 10.1093/bioinformatics/btp616.
   PubMed Web of Science ®Google Scholar
• Seufferlein T, Uhl W, Kornmann M, Algül H, Friess H, König A, Ghadimi M, Gallmeier E, Bartsch DK, Lutz MP, et al. 2023. Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group. Ann Oncol. 34(1):91–100. doi: 10.1016/j.annonc.2022.09.161.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Y, Dong H, Niu K, Zhang W, Feng K, Yang R, Zhang Y. 2023. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy. Apoptosis. 28(9-10):1423–1435. doi: 10.1007/s10495-023-01868-8.
   PubMed Web of Science ®Google Scholar
• Sun W, Ren Y, Lu Z, Zhao X. 2020. The potential roles of exosomes in pancreatic cancer initiation and metastasis. Mol Cancer. 19(1):135. doi: 10.1186/s12943-020-01255-w.
   PubMed Web of Science ®Google Scholar
• Tanase C, Gheorghisan-Galateanu A-A, Popescu ID, Mihai S, Codrici E, Albulescu R, Hinescu ME. 2020. CD36 and CD97 in pancreatic cancer versus other malignancies. Int J Mol Sci. 21(16):5656. doi: 10.3390/ijms21165656.
   Web of Science ®Google Scholar
• Torphy RJ, Fujiwara Y, Schulick RD. 2020. Pancreatic cancer treatment: better, but a long way to go. Surg Today. 50(10):1117–1125. doi: 10.1007/s00595-020-02028-0.
   PubMed Web of Science ®Google Scholar
• Weigel AV, Chang C-L, Shtengel G, Xu CS, Hoffman DP, Freeman M, Iyer N, Aaron J, Khuon S, Bogovic J, et al. 2021. ER-to-Golgi protein delivery through an interwoven, tubular network extending from ER. Cell. 184(9):2412–2429 e16. doi: 10.1016/j.cell.2021.03.035.
   PubMed Web of Science ®Google Scholar
• Wickham H. 2009. Ggplot2: elegant graphics for data analysis.
   Google Scholar
• Wilbur HC, Durham JN, Lim SJ, Purtell K, Bever KM, Laheru DA, De Jesus-Acosta A, Azad NS, Wilt B, Diaz LA, et al. 2023. Gemcitabine, docetaxel, capecitabine, cisplatin, irinotecan as first-line treatment for metastatic pancreatic cancer. Cancer Res Commun. 3(8):1672–1677. doi: 10.1158/2767-9764.CRC-23-0230.
   PubMedGoogle Scholar
• Wood LD, Canto MI, Jaffee EM, Simeone DM. 2022. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 163(2):386–402 e1. doi: 10.1053/j.gastro.2022.03.056.
   PubMed Web of Science ®Google Scholar
• Wortzel I, Dror S, Kenific CM, Lyden D. 2019. Exosome-mediated metastasis: communication from a distance. Dev Cell. 49(3):347–360. doi: 10.1016/j.devcel.2019.04.011.
   PubMed Web of Science ®Google Scholar
• Xia R, Hu C, Ye Y, Zhang X, Li T, He R, Zheng S, Wen X, Chen R. 2023. HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1. Int J Oncol. 62(4):45. doi: 10.3892/ijo.2023.5493.
   Web of Science ®Google Scholar
• Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, Liu M, Xu C, Zhang Q, Zhu H, et al. 2019. ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells. Gastroenterology. 156(3):722–734 e6. doi: 10.1053/j.gastro.2018.10.026.
   PubMed Web of Science ®Google Scholar
• Zagidullin B, Pasanen A, Loukovaara M, Bützow R, Tang J. 2022. Interpretable prognostic modeling of endometrial cancer. Sci Rep. 12(1):21543. doi: 10.1038/s41598-022-26134-w.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Liu W. 2020. Pancreatic cancer: a review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 19:1533033820962117. doi: 10.1177/1533033820962117.
   Web of Science ®Google Scholar
• Zhou B, Song H, Xu W, Zhang Y, Liu Y, Qi W. 2022. The comprehensive analysis of hub gene ARRB2 in prostate cancer. Dis Markers. 2022:8518378. doi: 10.1155/2022/8518378.
   PubMed Web of Science ®Google Scholar